US HB4363 | 2023-2024 | 118th Congress

Status

Spectrum: Strong Partisan Bill (Democrat 35-2)
Status: Introduced on June 23 2023 - 25% progression
Action: 2023-06-29 - Referred to the Subcommittee on Health.
Pending: House Subcommittee on Health Committee
Text: Latest bill text (Introduced) [PDF]

Summary

To address the health of cancer survivors and unmet needs that survivors face through the entire continuum of care from diagnosis through active treatment and posttreatment, in order to improve survivorship, treatment, transition to recovery and beyond, quality of life and palliative care, and long-term health outcomes, including by developing a minimum standard of care for cancer survivorship, irrespective of the type of cancer, a survivor's background, or forthcoming survivorship needs, and for other purposes.

Tracking Information

Register now for our free OneVote public service or GAITS Pro trial account and you can begin tracking this and other legislation, all driven by the real-time data of the LegiScan API. Providing tools allowing you to research pending legislation, stay informed with email alerts, content feeds, and share dynamic reports. Use our new PolitiCorps to join with friends and collegaues to monitor & discuss bills through the process.

Monitor Legislation or view this same bill number from multiple sessions or take advantage of our national legislative search.

Title

Comprehensive Cancer Survivorship Act

Sponsors


History

DateChamberAction
2023-06-29HouseReferred to the Subcommittee on Health.
2023-06-23HouseReferred to the Committee on Energy and Commerce, and in addition to the Committees on Ways and Means, and Education and the Workforce, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
2023-06-23HouseIntroduced in House

Same As/Similar To

SB2213 (Same As) 2023-06-22 - Read twice and referred to the Committee on Finance.

Subjects


US Congress State Sources


Bill Comments

feedback